Thursday, December 19, 2024

Clario partners with Emsere to extend ophthalmic medical imaging capabilities for clinical trials

Clario, a healthcare research and technology company that delivers leading endpoint solutions for clinical trials, is pleased to announce a strategic partnership with Emsere, a trusted medical equipment supplier for clinical trials. The collaboration provides a comprehensive, end-to-end solution that streamlines the execution of clinical trials requiring ophthalmic medical imaging and equipment.

Central to this partnership is Emsere’s global presence, which complements Clario’s commitment to delivering tailored solutions that address the challenges of each trial phase and modality. This relationship is significant because it will cater to sites that lack the necessary equipment to meet study protocols.

Customers of Clario and Emsere can now benefit from a unified approach, combining Clario’s clinical trial expertise and manufacturer-agnostic ophthalmic software with Emsere’s services for supplying, training, and maintaining imaging equipment.

Also Read: TELA Bio Appoints Greg Firestone as Chief Commercial Officer

“We’re thrilled to partner with Emsere in pursuit of our mutual goals,” said Joyce Suhy, Ph.D., Executive Vice President, Medical Imaging and Specialty Solutions at Clario. “This collaboration underscores our shared commitment to providing a solution tailored to meet the diverse needs in clinical trials.” Dr. Suhy continued: “Our objective is to streamline every aspect of the process. By leveraging our collective expertise, we’ll deliver solutions that simplify image capture, enhance quality assessment, and optimize analysis procedures. Furthermore, we’re mindful of the challenges encountered by trial sites that lack the equipment to meet protocol requirements. This solution includes support and strategies to address these challenges effectively.”

SOURCE: PRNewswire

Subscribe Now

    Hot Topics